In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JOINT VENTURE SAFETY ZONE FOR EXISTING HIGH-TECH MEDICAL EQUIPMENT

This article was originally published in The Gray Sheet

Executive Summary

JOINT VENTURE SAFETY ZONE FOR EXISTING HIGH-TECH MEDICAL EQUIPMENT is established by the Federal Trade Commission and Justice Department in a revised document on health care antitrust enforcement guidelines issued Sept. 27. The inclusion of joint ventures involving already purchased devices broadens the scope of the antitrust safety zone for shared "high-technology or other expensive medical equipment" set up in September 1993 by the agencies. The original safety zone was only for newly purchased equipment ("The Gray Sheet" Sept. 20, 1993, p. 21)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel